Novartis licenses vaccine candidates from U.S. group
12/29/2008
Novartis AG will license a program of vaccines from U.S. group AlphaVax against cytomegalovirus (CMV) infections, which can cause disability in newborn babies, the Swiss drugmaker said on Monday.
More: - Read More
Post Comment
Entry 1 of 16100
Last Page | Next Page









